Interestingly, upregulation of CD200, CD99 and PECAM1 in the FA predicted AML cells, in comparison to Healthy or FA non_AML cells (Fig 4A), opens the possibility to discover novel AML-associated markers, especially in the FA context. The gene discussed is CD99; the disease is acute myeloid leukemia.